Soft Tissue Sarcomas: Clinical Trials

3 trials for Soft Tissue Sarcomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Soft Tissue Sarcomas: new trials by email Literature Review of Soft Tissue Sarcomas trials Research Report on Soft Tissue Sarcomas

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Axitinib, Pembrolizumab - Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas
Phase 2CompletedJonathan Trent, MD, PhD332016-04-192024-07-12
RAD001 in Advanced Sarcoma
RAD001 - Soft Tissue Sarcomas, Bone Sarcomas
Phase 2CompletedAsan Medical Center412010-04-012013-04-12
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).
AZD2171 - Gastrointestinal Stromal Tumors, Soft Tissue Sarcomas
Phase 2CompletedAstraZeneca352006-09-012012-07-16

Narrower conditions

Sarcoma (3)  ·  Bone Neoplasms (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Neoplasms (1)  ·  Sarcoma, Alveolar Soft Part (1)

Broader conditions

Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Neoplasms (2)  ·  Bone Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Muscle Tissue (1)

Interventions

Axitinib (1)  ·  Everolimus (1)  ·  cediranib (1)  ·  pembrolizumab (1)

Sponsors

Asan Medical Center (1)  ·  AstraZeneca (1)  ·  Jonathan Trent, MD, PhD (1)

Countries

South Korea (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Jane Robertson, MD (1)  ·  Jin-Hee Ahn, MD, PhD (1)  ·  Jonathan C Trent, MD (1)

Results publications

PMID 24037083, PMID 24714778, PMID 31078463